4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001179110-20-010367
Chief Executive Officer sold 30,000 shares at $222.26 ($6,667,800)
- Chief Executive Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOREVIC JASON N Chief Executive Officer | 2020-10-06 | Option exercise | +30,000 | $6.01 | $180,300 | 697,283 | D: show line 1 in the form |
| GOREVIC JASON N Chief Executive Officer | 2020-10-06 | Sale | −30,000 | $222.26 | $6,667,800 | 667,283 | D: show line 2 in the form |
| Open-market sales · 30,000 sh · avg $222.26 · $6,667,800 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GOREVIC JASON N Chief Executive Officer | 2020-10-06 | Option exercise · Employee Stock Option (right to buy) | −30,000 | 310 | D: show line 3 in the form |
Loading xslF345X03/edgar.xml…